Hematologic Malignancy
Cutaneous Mature T-Cell and NK-Cell Neoplasm
CI-CAN-00000794Explore in graph →
HematologicNon-malignant59 active trials10 approved drugs
- NCIt
- C45250
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000794Explore in graph →
Clinical trials
329 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01746992 | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma | unknown | Phase 4 | 200 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 14, 2017source: clinicaltrials